Marpai (MRAI) Registration Filing summary

Company overview and business model

• Operates as a national TPA using AI and data analytics to help self-insured employers manage healthcare costs and improve outcomes for employees and families.

• Offers health plan administration, in-house ancillary services (e.g., care management, pharmacy advocacy), and third-party vendor services.

• Focuses on small and medium-sized businesses and local government entities, leveraging technology to differentiate in a highly competitive TPA market.

• Revenue sources include administration fees, ancillary services, and pass-through fees from third-party vendors.

Financial performance and metrics

• For the nine months ended September 30, 2024, revenue was $21.6M, down 24% from $28.4M in the prior year period, primarily due to customer turnover.

• Net loss for the nine months ended September 30, 2024 was $20.9M, compared to $23.7M in the prior year period.

• As of September 30, 2024, accumulated deficit was $97.7M, with $830K in unrestricted cash and negative working capital of $3.3M.

• Goodwill and intangible assets were fully impaired in June 2024, resulting in a $7.6M charge.

• For the year ended December 31, 2023, revenue was $37.2M, up 53% from $24.3M in 2022, mainly due to the Maestro Health acquisition.

• Net loss for 2023 was $28.8M, compared to $26.5M in 2022.

Use of proceeds and capital allocation

• Will not receive proceeds from the resale of 5,705,996 shares by selling stockholders; all registration costs are borne by the company.

• Proceeds from recent private placements and convertible debentures have been used to fund operations and repay debt.

• Ongoing efforts to raise additional capital through equity or debt; asset sales considered for non-strategic assets.